stress-induced injury in cultured cardiomyocytes 5 and exert beneficial cardiac effects during pressure overload in vivo. 6 However, neither how it is activated in the overloaded heart nor the mechanisms underlying its protective effects are known.
Recent studies indicate that the ROS-generating enzyme nicotinamide adenine dinucleotide phosphate oxidase-4 (Nox4) exerts beneficial cardiac and vascular effects during chronic hemodynamic stress. 7, 8 Nox4 is a member of the Nox family proteins that differ from most other ROS-generating enzymes in that ROS production is their primary function. Nox enzymes generate ROS using nicotinamide adenine dinucleotide phosphate as an electron donor and are involved in redox signaling in many tissues. 9 The Nox isoenzymes present in the cardiovascular system, ie, Nox1/2/4/5, have distinct tissue distributions and subcellular localization. Among these, Nox4 is unique in being constitutively active and regulated predominantly by changes in abundance. Nox4 was shown to protect the heart during chronic pressure overload, at least in part through a hypoxia-inducible factor-1-mediated increase in myocardial capillary density. 7 Intriguingly, the beneficial vascular effects of Nox4 in a model of inflammatory injury were attributed, at least in part, to an induction of Nrf2. 8 Forced overexpression of Nox4 activates the Nrf2 pathway, 10 as expected with maneuvers that increase ROS levels, 3 but the endogenous source(s) of ROS responsible for activating Nrf2 during hemodynamic stress is unknown.
This study investigated the role of endogenous Nox4 in physiologically activating Nrf2 and the mechanisms through which Nrf2 activation influences functional outcome in the chronically overloaded heart.
Materials and Methods
Detailed Materials and Methods are provided in the online-only Data Supplement.
Animal procedures were performed in accordance with UK national guidelines. Nrf2 , and cardiomyocyte-targeted Nox4 transgenic (Nox4TG) mice were described previously.
7,10 Aortic constriction or sham surgery and echocardiography were performed as described. 7 Cardiomyocyte area, interstitial fibrosis, and capillary density were quantified in heart sections. 7 Apoptosis was assessed by terminal deoxynucleotidyl transferase deoxyuridine triphosphate nick end labeling staining. Mitochondrial DNA (mtDNA) damage was assessed with a quantitative polymerase chain reaction-based assay in which the amount of a 10-kb mtDNA polymerase chain reaction product is inversely related to DNA damage. 11 Protein carbonyl levels were measured using a spectrophotometric kit (Cell Biolabs, Cambridge, United Kingdom). Neonatal rat ventricular myocytes (NRVM) were prepared as described. 7 Data are presented as mean±SEM. Comparisons were made by 1-way or repeated measures ANOVA, followed by Bonferroni test for multiple comparisons. P<0.05 was considered significant.
Results

Upregulation of an Nrf2-Regulated Gene Program During Chronic Pressure Overload
Nrf2 protein levels were significantly upregulated in the myocardium of wild-type (WT) mice after aortic constriction ( Figure 1A ). Pressure overload significantly increased the mRNA expression of the Nrf2 targets glutamate-cysteine ligase (Gclc), glutathione-S-transferase α2 (Gsta2), and heme oxygenase 1 (Hmox1) in WT littermates but not in Nrf2 −/− mice ( Figure 1B-1D ). Levels of nicotinamide adenine dinucleotide phosphate-quinone-oxidoreductase 1 (Nqo1), catalase (Cat), and thioredoxin reductase 1 (Txnrd1) were lower in Nrf2 −/− animals than in WT littermates, but pressure overload per se did not alter expression levels ( Figure 1E-1G ).
Nrf2-Null Mice Develop Exacerbated Pressure Overload-Induced Cardiac Dysfunction
Nrf2
−/− mice and WT littermates had similar baseline cardiac dimensions and contractile function by echocardiography groups ( Figure S1 in the online-only Data Supplement). After 6 weeks of suprarenal abdominal aortic constriction, Nrf2 −/− mice developed significantly greater cardiac dilatation and contractile impairment than WT littermates ( Figure S1 ). Nrf2 −/− mice developed greater cardiac hypertrophy than WT littermates, both at whole heart and cardiomyocyte level, as well as larger increases in atrial natriuretic peptide (Nppa) and β-myosin heavy chain (Myh7) mRNA levels ( Figure S1D -S1H). Nrf2-null animals also developed more interstitial fibrosis than WT littermates after aortic constriction ( Figure S1I ) but had a similar reduction in myocardial capillary density ( Figure S1J ).
Nrf2 Deficiency Increases Myocardial
Oxidative Stress, mtDNA Damage, and Caspase
3-Independent Cell Death
To assess mechanisms underlying the protective effects of Nrf2 during hemodynamic stress, we first assessed oxidative stress. The myocardial protein carbonyl content was substantially higher in Nrf2 −/− mice than in WT littermates after pressure overload (Figure 2A ). We found significantly higher levels of mtDNA damage in Nrf2 −/− hearts than in WT littermates ( Figure 2B ). Myocardium of Nrf2 −/− mice also showed more terminal deoxynucleotidyl transferase deoxyuridine triphosphate nick end labeling-positive cells than that of WT littermates under stress ( Figure 2C ).
To investigate how Nrf2-related oxidative stress and mitochondrial dysfunction modulate cell death, we first assessed the release of cytochrome c from mitochondria into the cytosol, which is associated with caspase 3-mediated apoptosis. 12 There was difference neither in cytosolic cytochrome c levels between myocardium of Nrf2 −/− mice and that of WT littermates nor in the levels of cleaved caspase 3 or Bcl-2 protein among groups ( Figure S2A -S2C). Apoptotic cell death pathways can be amplified through cleavage of the Bcl-2 family protein BH3-interacting domain death agonist (Bid) by caspase 8 to form truncated Bid, which contributes to outer mitochondrial membrane events. 13, 14 Pressure-overloaded hearts of Nrf2 −/− mice showed significantly increased caspase 8 levels compared with that of Nrf2 −/− sham-operated animals, whereas caspase 8 levels were unaffected by overload in WT littermates ( Figure 3A ). The truncated Bid:uncleaved Bid ratio was also significantly increased in Nrf2 −/− hearts under stress ( Figure 3B) .
A cytochrome c-independent mechanism downstream of caspase 8/truncated Bid activation is the cleavage of mitochondrial apoptosis-inducing factor (AIF) and its nuclear translocation to mediate damage through binding to DNA. 15, 16 There was a substantial increase in cleaved AIF in nuclear and total fractions from hearts of Nrf2 −/− mice compared with WT littermates after pressure overload ( Figures 3C and S2D , respectively). Nuclear DNA damage, assessed by the levels of phosphorylated H 2 AX (γ-H 2 AX) that is activated in response to DNA double-strand breaks, 17 was also significantly higher in Nrf2 −/− hearts ( Figure 3D ).
Endogenous Nox4 Activates Cardiomyocyte Nrf2 During Overload Stress
We next investigated the relationship between cardiomyocyte Nrf2 activation and the increase in Nox4 levels that also occurs during hemodynamic overload. 7 In cultured NRVM treated with phenylephrine to simulate hemodynamic stress, there was a significant increase in Nox4 and Nrf2 protein levels ( Figure 4A and 4B). Phenylephrine-induced increases in Nrf2 were abrogated by shRNA-mediated knockdown of Nox4 ( Figure 4B ). Phenylephrine upregulated the Nrf2 target genes Hmox1, Gclc, and Gstα2, and these increases were abolished in cells in which either Nox4 or Nrf2 had been knocked down ( Figures 4C-4E and S3A-S3D, respectively). We tested the effects of knocking down Nox2, a Nox isoform that is also upregulated by phenylephrine, but this did not affect the changes in Nrf2 protein levels or Nrf2 target genes in NRVM ( Figure S3E-S3I) . In NRVM in which Nox4 levels had been knocked down (and where the phenylephrineinduced increase in Nrf2 target genes was blunted), the activation of Nrf2 by knockdown of Kelch-like ECH-associated protein 1 resulted in significant upregulation of Nrf2 target genes ( Figure S4 ), indicating that the Nrf2 pathway downstream of Nox4 remained intact.
To extend these results to the in vivo setting, we studied Nox4 −/− mice and WT littermates. Basal Nrf2 levels were slightly higher in Nox4 −/− mice than in WT littermates, but the stress-induced upregulation of Nrf2 observed in WT littermates after aortic constriction was completely abolished in Nox4 −/− mice ( Figure 5A ). The basal mRNA levels of Gclc, Hmox1, and Gsta2 were similar in WT and Nox4 −/− mice, but the upregulation observed in WT littermates after aortic constriction was inhibited in Nox4 −/− mice ( Figure 5B-5D ). No differences were observed in Cat, Nqo1, or Txnrd1 mRNA levels in either group ( Figure S5 ). Taken together, these results identify Nox4 as a crucial endogenous upstream regulator of Nrf2 activation in the heart during hemodynamic stress.
Role of Nrf2 Activation in the Cardioprotective Effects of Nox4 During Pressure Overload
We previously reported that myocardial Nox4 is protective against the detrimental consequences of chronic pressure overload, 7 and we report here that Nrf2 also exerts similar protective effects. To determine the contribution of Nrf2 to the protective effects of Nox4, we undertook crosses of cardiomyocyte-specific Nox4TG and Nrf2 +/− mice to generate Nox4TG/Nrf2 +/+ and Nox4TG/Nrf2 −/− mice. These animals, as well as WT and Nrf2 −/− mice, were subjected to chronic aortic constriction.
Echocardiography showed that Nox4TG/Nrf2 +/+ mice developed less cardiac dysfunction, dilatation, and hypertrophy than WT littermates ( Figures 6A-6D and S6 ). Genetic deletion of Nrf2 in Nox4TG significantly blunted the protective effects of Nox4; thus, Nox4TG/Nrf2 −/− mice exhibited worse contractile dysfunction and hypertrophy than Nox4TG/Nrf2 +/+ mice ( Figures 6 and S6) . These results suggest that Nrf2 activation downstream of myocardial Nox4 contributes significantly to the protective effects of Nox4 during pressure overload. 
Discussion
Nrf2 controls the basal and inducible expression of numerous antioxidant proteins, detoxifying enzymes, and cytoprotective molecules, thereby exerting protective effects in disease settings. Previous work suggested that Nrf2 exerts cardioprotective effects, 5, 6, 18 but the mechanisms underlying its upregulation during hemodynamic overload or its protective effects are unknown. Here, we report the novel findings that Nrf2 activation is under the regulation of endogenous Nox4 and it mediates protective effects in the pressureoverloaded heart via a caspase 8/Bid/AIF pathway to promote cell survival. These data identify a novel endogenous cytoprotective pathway involving specific ROS-antioxidant signaling that regulates the cardiac response to chronic overload stress. Our study confirms the results of a previous study in Nrf2-deficient mice that reported the protective effects of Nrf2 during hemodynamic overload, 6 but additionally it sheds light on mechanisms. We found that Nrf2 deficiency was associated with increased oxidative stress and a substantial increase in mtDNA damage during pressure overload, which is consistent with the fact that mitochondria are targets of oxidative damage. 19 Interestingly, not all Nrf2 target genes were affected either by pressure overload or by Nrf2 deficiency, most likely because additional transcription factors may be involved in regulating these genes. 3 We found that the cell death accompanying mtDNA damage was independent of caspase 3/cytochrome c and instead related to a caspase 8/ Bid/AIF pathway. Protein levels of caspase 8 were lower at baseline in Nrf2 −/− mice than in WT littermates but rose to a greater extent after stress, suggesting that the magnitude of stress-related increase may be more important than absolute levels. Nrf2
−/− mice also demonstrated increased AIF cleavage and translocation to the nucleus, which is consistent with previous data that AIF release from mitochondria occurs downstream of caspase 8/Bid activation. 15 Nuclear translocation of AIF mediates DNA damage, 16, 20 and we found evidence of increased nuclear DNA damage in Nrf2 −/− mice after pressure overload.
In the previous work, we showed that upregulation of cardiomyocyte ROS-generating Nox4 beneficially affects cardiac remodeling during chronic pressure overload. 7 Because Nrf2 may be activated by ROS, we investigated whether Nox4 is involved in activating Nrf2. Remarkably, both phenylephrine-induced Nrf2 activation in NRVM and pressure overload-induced cardiac activation in vivo required endogenous Nox4. Notably, the knockdown of a different Nox isoform, Nox2, failed to inhibit Nrf2 activation. Whereas diverse ROS sources can activate Nrf2, these findings indicate that cardiomyocyte Nox4 serves as a specific and indispensable endogenous activator of Nrf2 signaling during pressure overload. This could be related to the specific subcellular localization of Nox4 or specific signaling linking Nox4 and Nrf2, although this is speculative at this stage. We noted that although Nrf2 activation was inhibited in Nox4-null mice after aortic constriction, basal Nrf2 levels were slightly higher in Nox4-null mice than in WT littermates. This may be because of adaptive responses to a chronically compromised redox state in Nox4-null animals 8 because the Nrf2 pathway itself remains intact.
Having identified Nox4 as an upstream regulator of Nrf2 activation, it was of interest to assess the contribution of Nrf2 activation to the protective effects of Nox4. Using a genetic approach to ablate Nrf2 activation in mice with cardiomyocyte-targeted Nox4 overexpression, we found that Nrf2 plays a significant role in Nox4-dependent protection. Previously, we found that an important mechanism contributing to the Nox4 protective effect was an increase in myocardial capillary density. 7 In the current study, Nrf2 deficiency had no effect on myocardial capillary density during pressure overload, indicating that the protective effects of Nox4 are mediated by multiple mechanisms (including Nrf2 activation). Indeed, other Nox4-mediated beneficial cardiac effects were reported in the context of ischemia-reperfusion, although detrimental effects of Nox4 related to excessive ROS production were also reported. 21, 22 Therefore, the effects of Nox4 and the signaling pathways engaged downstream of its activation may vary depending on the precise disease condition.
Perspectives
Increased oxidative stress is considered detrimental in the chronically overloaded heart or failing heart, but clinical trials of antioxidant vitamins were unsuccessful. 23 One reason may be that such approaches provide only simple antioxidant supplementation, whereas the endogenous cytoprotective program activated by Nrf2 enhances not only antioxidant enzymes but also conjugation and detoxification enzymes that deal with toxic electrophiles, transporters that efflux toxic conjugates, and many other proteins. The recent development of small molecule activators of the Nrf2 pathway 24 may be a promising alternative approach. Furthermore, simple antioxidant approaches may paradoxically disrupt endogenous protective pathways, such as the Nox4-mediated Nrf2 activation identified in the current study. Therefore, the current results support targeted interventions to modulate endogenous antioxidant systems as a better therapeutic approach than simple antioxidant supplementation. 
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ONLINE SUPPLEMENT
NOX4-DEPENDENT UPREGULATION OF NRF2 PROTECTS THE HEART DURING CHRONIC PRESSURE OVERLOAD
MATERIALS AND METHODS
Animal studies
Nrf2
-/-, Nox4 -/-and cardiomyocyte-targeted Nox4 transgenic (Nox4TG) mice were described previously 1, 2 . To ensure that any effects observed in Nox4TG were not related to the site of integration of the transgene, we generated two independent Nox4 trangenic lines which both showed similar phenotypes at baseline and after aortic banding 1 . Male mice and littermate wild-type (WT) controls underwent aortic constriction or sham surgery under 2% isoflurane anesthesia 1 .
Aortic constriction
All procedures were performed in accordance with the Guidance on the Operation of the Animals (Scientific Procedures) Act, 1986 (United Kingdom). We studied male mice and respective matched wild-type (WT) littermates, all on a C57BL/6 background. Aortic constriction was performed in 16-18g mice by a single surgeon, using suprarenal banding with a 27 gauge band under 2% isoflurane anesthesia 3 . Sham constriction involved identical surgery apart from band placement. Increases in invasively measured peak aortic systolic pressure ranged from 21.7±6.0 to 22.4±2.2 mmHg, consistent across groups. Animals were studied up to 6 weeks post-surgery.
Echocardiography
Echocardiography was performed under 1.5% isoflurane using a Visualsonics Vevo 2100 ultrasound system with a 40-MHz transducer 1 . Heart rates were above 400 bpm in all experiments. Analysis of data was performed using the VevoStrain software package (Visualsonics).
cDNA synthesis and real time qPCR
Total RNA was reversed-transcribed using random decamers with M-MLV RT (Promega, UK) for heart tissue or cardiomyocyte samples according to the manufacturer's protocol. Control reactions omitting the RT were also performed in all cases. An Eppendorf Mastercycle Realplex detection system (Eppendorf, UK) using SYBR Green and the comparative Ct method was used, with cytoskeletal β-actin levels employed for normalization. Primer sequences are provided in Table S1 .
Histology sequences) was amplified to increase the probability that the polymerase will encounter damaged DNA regions. QPCR was performed with the GeneAmp XL PCR system (Applied Biosystems), which uses rTth DNA polymerase XL enzyme designed to amplify target DNA sequences up to 40 kb. All reactions were initiated by a hot start (75 o C, 2 min) prior to the addition of the rTth enzyme (Table S2 for QPCR conditions). We normalised QPCR results for mitochondrial copy number to ensure that changes in amplification levels are accurate reflections of DNA damage and not affected by fluctuation in the amount of mitochondrial DNA present in each sample. This was performed via amplification of a small mitochondrial target (~200 bp) whose amplification would not be significantly affected by DNA damage.
DNA damage was quantified by comparing the amount of the large mitochondrial DNA fragment (~10 kb) amplified from heart samples of interest compared to amplification obtained from heart samples of WT sham controls. Large and small mitochondrial QPCR products were semi-quantified on 0.8% and 2% agarose gels respectively and the resulting values were expressed as relative probability of mtDNA lesions by application of the Poisson distribution [lesions/amplicon = -ln(sample of interest/WT Sham)].
Other assays
Protein oxidation was assessed by measurement of protein carbonyl levels using a spectrophotometric kit (Cell Biolobs, UK). Cytochrome c translocation from the mitochondria to the cytosol was measured with a cytochrome c release assay kit (Abcam, UK).
Statistics
Data are presented as mean ± SEM. Comparisons were made by 1-way or repeated measures ANOVA, followed by Bonferroni test for multiple comparisons. P < 0.05 was considered significant. 
